Early Blood Test Signals Alzheimer's Risk Long Before Scans
TL;DR Summary
A long-term study of cognitively healthy adults found that plasma pTau217 levels forecast early Alzheimer’s pathology and future cognitive decline, often rising years before amyloid PET scans become positive, suggesting blood tests could enable earlier risk detection and screening for prevention trials.
- Simple Blood Test May Predict Alzheimer’s Years Before Brain Scans Show Signs SciTechDaily
- Enhance Neurodegenerative Detection and Monitoring with BD-pTau 217 and α-Syn, Upcoming Webinar Hosted by Xtalks PR Newswire
- Early Immune Changes May Signal Increased Risk of Alzheimer’s & Dementia NYU Langone Health
- Groundbreaking dementia trial underway at Hampshire NHS trust Basingstoke Gazette
- A Promising Study Suggests a Blood Test Could Spot Alzheimer’s Early in Progression Mount Sinai
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
7 min
vs 8 min read
Condensed
97%
1,415 → 42 words
Want the full story? Read the original article
Read on SciTechDaily